REGENXBIO

Regenxbio

Biotechnology, 9804 Medical Center Dr, Rockville, Maryland, 20850, United States, 201-500 Employees

regenxbio.com

  • twitter
  • LinkedIn

phone no Phone Number: 24********

Who is REGENXBIO

REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adenoassociated virus (AAV) gene therapy. REGENXBIO's NAV Technolog...

Read More

map
  • 9804 Medical Center Dr, Rockville, Maryland, 20850, United States Headquarters: 9804 Medical Center Dr, Rockville, Maryland, 20850, United States
  • 2008 Date Founded: 2008
  • 201-500 Employees: 201-500
  • dollar-icon Revenue: $250 Million to $500 Million
  • tech-icon Active Tech Stack: See technologies
  • Lisa Reid CEO:   Lisa Reid

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from REGENXBIO

REGENXBIO Org Chart and Mapping

Lisa Reid

Executive Assistant to Chief Executive Officer

Employees

Taja Stancil

QA Operations Specialist II

Sheyla Finkner

Associate Formulations & Drug Product Development Scientist III

Lydia Joyner

Target Discovery Research Intern

Ariana Pjetri

Clinical Development Intern

Salma Mahzoon

Scientist I (Analytical Development/ Potency)

Gary Chan

Research Scientist II, Preclinical Development, Pharmacokinetics

Jeffrey Levine

Senior Bioprocess Engineer, Msat

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding REGENXBIO

Answer: REGENXBIO's headquarters are located at 9804 Medical Center Dr, Rockville, Maryland, 20850, United States

Answer: REGENXBIO's phone number is 24********

Answer: REGENXBIO's official website is https://regenxbio.com

Answer: REGENXBIO's revenue is $250 Million to $500 Million

Answer: REGENXBIO's SIC: 2836

Answer: REGENXBIO's NAICS: 541714

Answer: REGENXBIO has 201-500 employees

Answer: REGENXBIO is in Biotechnology

Answer: REGENXBIO contact info: Phone number: 24******** Website: https://regenxbio.com

Answer: REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adenoassociated virus (AAV) gene therapy. REGENXBIO's NAV Technology Platform, a proprietary AAV gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. REGENXBIO's mission is to transform the lives of patients suffering from severe diseases with significant unmet medical need by developing and commercializing in vivo gene therapy products based on REGENXBIO's NAV Technology Platform. REGENXBIO seeks to accomplish this mission through a combination of internal development efforts and thirdparty NAV Technology Platform licensees.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access